We are live on !
Find out more
Proffitt & Goodson Portfolio holdings
AUM
$722M
Turnover
8.57%
1-Year Est. Return
12.42%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+12.42%
3 Year Est. Return
+54.01%
5 Year Est. Return
+43.49%
10 Year Est. Return
+147.47%
AUM
$228M
AUM Growth
+$4M
(+1.8%)
Cap. Flow
-$4.64M
Cap. Flow % of AUM
Cap. Flow %
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
81.28%
Holding
50
New
1
Increased
3
Reduced
42
Closed
1
Avg Time Held
2.8
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.24M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.48M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$39.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.63M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.24M |
| 3 |
Du Pont De Nemours E I
DD
|
+$979K |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$355K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$344K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.52% |
| 2 | Technology | 3.69% |
| 3 | Industrials | 2.23% |
| 4 | Healthcare | 2.15% |
| 5 | Financials | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$804B
| $63.7M | 27.96% |
253,619
-18,762
| -7% | -$4.63M |
2013 Q2
17 quarters
|
|
|
2
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $43.9M | 19.26% |
1,011,217
+76,445
| +8% | +$3.24M |
2013 Q2
17 quarters
|
|
|
3
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
| $25.7M | 11.28% |
198,563
-9,767
| -5% | -$1.24M |
2013 Q2
17 quarters
|
|
|
4
iShares Russell 2000 ETF
IWM
$77.5B
| $14.8M | 6.49% |
99,850
-2,448
| -2% | -$344K |
2013 Q2
17 quarters
|
|
|
5
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $14M | 6.15% |
284,284
-7,356
| -3% | -$355K |
2013 Q2
17 quarters
|
|
|
6
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $13.3M | 5.82% |
304,229
+29,736
| +11% | +$1.29M |
2013 Q2
17 quarters
|
|
7
Vanguard Information Technology ETF
VGT
$140B
| $3.56M | 1.56% |
187,336
-10,872
| -5% | -$201K |
2017 Q1
2 quarters
|
|
8
State Street Health Care Select Sector SPDR ETF
XLV
$50.9B
| $2.2M | 0.97% |
26,936
-1,829
| -6% | -$147K |
2013 Q2
17 quarters
|
|
9
State Street Financial Select Sector SPDR ETF
XLF
$55.3B
| $2.14M | 0.94% |
82,757
-6,051
| -7% | -$151K |
2013 Q2
17 quarters
|
|
10
Apple
AAPL
$5.17T
| $1.96M | 0.86% |
50,804
-2,008
| -4% | -$77.9K |
2013 Q2
17 quarters
|
|
11
State Street SPDR S&P Regional Banking ETF
KRE
$4.7B
| $1.86M | 0.82% |
32,734
-1,601
| -5% | -$86K |
2014 Q1
14 quarters
|
|
12
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $1.82M | 0.8% |
40,484
-2,358
| -6% | -$106K |
2013 Q2
17 quarters
|
|
13
Leidos
LDOS
$16B
| $1.63M | 0.71% |
27,461
| – | – |
2016 Q1
6 quarters
|
|
14
Microsoft
MSFT
$3.87T
| $1.51M | 0.66% |
20,325
-1,181
| -5% | -$86.3K |
2013 Q2
17 quarters
|
|
|
15
Vanguard S&P 500 ETF
VOO
$1.05T
| $1.5M | 0.66% |
+6,514
| New | +$1.48M |
2017 Q3
0 quarters
|
|
16
Johnson & Johnson
JNJ
$686B
| $1.41M | 0.62% |
10,879
-852
| -7% | -$113K |
2013 Q2
17 quarters
|
|
17
Bank of America
BAC
$349B
| $1.37M | 0.6% |
54,026
-2,751
| -5% | -$66.8K |
2015 Q4
7 quarters
|
|
18
Intel
INTC
$327B
| $1.33M | 0.58% |
35,016
-2,447
| -7% | -$87K |
2013 Q2
17 quarters
|
|
19
Cisco
CSCO
$404B
| $1.33M | 0.58% |
39,589
-4,429
| -10% | -$141K |
2013 Q2
17 quarters
|
|
20
iShares Biotechnology ETF
IBB
$11.2B
| $1.32M | 0.58% |
11,919
-636
| -5% | -$68K |
2016 Q1
6 quarters
|
|
21
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $1.32M | 0.58% |
24,359
-2,559
| -10% | -$141K |
2017 Q2
1 quarter
|
|
22
JPMorgan Chase
JPM
$912B
| $1.29M | 0.57% |
13,536
-625
| -4% | -$57.6K |
2015 Q3
8 quarters
|
|
23
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.45B
| $1.28M | 0.56% |
39,724
-692
| -2% | -$22.5K |
2016 Q3
4 quarters
|
|
24
Amazon
AMZN
$2.9T
| $1.24M | 0.54% |
25,800
-800
| -3% | -$39.3K |
2016 Q2
5 quarters
|
|
25
Elevance Health
ELV
$93B
| $1.23M | 0.54% |
6,501
-757
| -10% | -$144K |
2014 Q4
11 quarters
|
|
Similar funds
Proffitt & Goodson's Q3 2017 Portfolio in Review
As of Q3 2017, Proffitt & Goodson held 50 positions worth $228M, up 1.8% from $224M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 4%. Proffitt & Goodson opened 1 new position and exited 1, leaving the 50-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 84% a quarter earlier, followed by Technology and Industrials.
- Proffitt & Goodson's largest Q3 2017 buy was Vanguard S&P 500 ETF: 6,514 shares worth $1.5M.
- Proffitt & Goodson added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $3.24M increase.
- Proffitt & Goodson's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.63M.
- Proffitt & Goodson fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $979K.
- Proffitt & Goodson's ten largest holdings make up 81% of its $228M portfolio in Q3 2017.
- Proffitt & Goodson opened 1 new position and closed 1 in Q3 2017.
- Proffitt & Goodson's portfolio value rose 1.8% quarter-over-quarter to $228M.
Based on Proffitt & Goodson's 13F filing for Q3 2017, filed 24 Oct 2017.